MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)

NCT02949908 · clinicaltrials.gov ↗
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped Delay in site selection and recruitment.

Conditions

Interventions

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators